APYX vs CTAS · rev $48.1M vs P/E 51, rev $10.34B
Apyx Medical Inc (APYX) versus Cintas Corporation (CTAS) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported CTAS revenue for 2025-05-31 was $10.34B. Net income was $1.81B. Revenue was up 7.7% from 2024-05-31 to 2025-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
APYX currently screens at market cap $179.6M. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Not investment advice. Open the APYX and CTAS stock pages for the full models.
Not investment advice.